Transcriptome Sequencing of Peripheral Blood Reveals Distinct Expression Landscapes of COVID-19 and MIS-C Patients Open Access

Guo, Nanxi (Spring 2021)

Permanent URL: https://etd.library.emory.edu/concern/etds/707958851?locale=en
Published

Abstract

Background: The pandemic spread of the coronavirus disease 2019 (COVID-19) has been proclaimed a severe public health emergency of international concern (PHEIC) by the WHO. Of note, children were reported symptoms similar to severe COVID-19, which has then been confirmed as a rare complication of COVID-19 in children, termed as multisystem inflammatory syndrome (MIS-C). However, little is known about its genetic mechanisms compared to COVID-19.

 

Methods: RNA-sequencing of blood transcriptome were performed from COVID-19 and MIS-C patients in both mild and severe scenarios, as well as healthy control samples. Then bioinformatic approaches were performed to identify distinct expression landscapes of COVID-19 and MIS-C patients.

 

Results: Peripheral blood transcriptomes of 8 COVID-19 patients, 15 MIS-C patients and 8 healthy controls were depicted here. Immune response of COVID-19 patients compared to healthy controls were first detected. Neutrophil activation-associated terms, lymphocyte differentiation terms, and cardiomyopathy-associated terms were more enriched in comparison between COVID-19 and MIS-C, in severe illness levels. Further analyses on immune molecular signatures by peripheral blood mononuclear cells (PBMC) revealed increasing of T cells (CD8+ T memory cell markers), CD14 cells in COVID-19 vs MIS-C comparison.

 

Conclusions: This study supported the clinical differentiation between MIS-C patients and COVID-19 patients in genetic way. Therefore, several evidence were provided for diagnostic biomarkers in COVID-19 and MIS-C patients, for better screening and diagnostics, and to treat patients with a personalized approach.

Table of Contents

Background 1

Methods 2

Human cohorts 2

RNA-sequencing 3

RNA-sequencing analysis 3

Results 4

Immune Response of COVID-19 Patients Compared to Healthy Controls 4

Differences in Gene Expression in COVID-19 Patients and MIS-C Patients 8

Immune Molecular Signatures of COVID-19 Patients Compared to MIS-C Patients 12

Discussion 14

References 20

 

About this Master's Thesis

Rights statement
  • Permission granted by the author to include this thesis or dissertation in this repository. All rights reserved by the author. Please contact the author for information regarding the reproduction and use of this thesis or dissertation.
School
Department
Subfield / Discipline
Degree
Submission
Language
  • English
Research Field
Keyword
Committee Chair / Thesis Advisor
Committee Members
Last modified

Primary PDF

Supplemental Files